Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® HCV / Hepatitis specialty page provides HCV / hepatitis-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


Researchers Find New Therapeutic Target Against Chronic Viral Infections
Researchers offer more insight on the role of IFN-I and find a potential therapeutic target that may be able to protect against chronic viral infections.
Blood Infections May Increase Risk of Arteriosclerosis
New research from the Medical University of Vienna has made a connect between blood infections and an increased risk of arteriosclerosis.
AbbVie's Investigational Drug Regimen Gives Genotype 1 HCV-infected Patients High Sustained Viral Response Rates
In a phase 3 clinical trial, Japanese patients with chronic hepatitis C (HCV) infection without liver cirrhosis were able to achieve high sustained viral response rates after taking an investigational HCV drug from AbbVie.
New Biotech Company Aims to Take Down Infectious Diseases
A new biotechnology company, Vir Biotechnology, is gunning for bear in the fight against infectious diseases and boasting a roster of heavy hitters in the industry.
Behavioral Traits Plague HCV Patients Who Achieve SVR But Still Have Higher Mortality
Despite the fact that an increasingly large portion of the hepatitis C (HCV)-infected population successfully achieves a cure for the infection, called sustained viral response (SVR), this population still deals with increased mortality rates.
What's New in 2017: Express Scripts Adds Hepatitis C Drug Harvoni to National List
Harvoni has been added to Express Script’s formulary and will be available from the company’s Hepatitis Cure Value Program.
Big advances in treatment can